Table: Jcr Pharmaceuticals -2023/24 group results

JCR Pharmaceuticals

26/06/2024 08:00

Jun 26 (Reuters)- 
          Jcr Pharmaceuticals Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             42.87           34.34          41.30                 
                 (+24.8 pct)     (-32.8 pct)    (-3.7 pct)               
  Operating          7.53            4.98           5.40                 
                 (+51.4 pct)     (-75.0 pct)    (-28.3 pct)              
  Recurring          7.26            5.42           4.60                 
                 (+34.1 pct)     (-73.6 pct)    (-36.7 pct)              
  Net
  Net                5.51            3.77           3.70                 
                 (+46.0 pct)     (-74.0 pct)    (-32.8 pct)              
  EPS             44.13 yen       30.35 yen      29.65 yen               
  EPS Diluted     43.92 yen       30.22 yen                              
  Ann Div         20.00 yen       20.00 yen      20.00 yen               
  -Q2 Div         10.00 yen       10.00 yen      10.00 yen               
  -Q4 Div         10.00 yen       10.00 yen      10.00 yen               
  
  NOTE - Jcr Pharmaceuticals Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T